DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Earl HM, Vallier AL, Hiller L et al.
Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2 × 2 factorial randomised phase 3 trial.
Lancet Oncol 2014;
15: 201-212
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.